Korea Otsuka Pharmaceutical Co., Ltd.
Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder
- Conditions
- Interventions
- First Posted Date
- 2008-06-27
- Last Posted Date
- 2013-07-26
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 61
- Registration Number
- NCT00706589
- Locations
- ๐ฐ๐ท
Seoul National University Hospital, Seoul, Korea, Republic of
๐ฐ๐ทInha University Hospital, Inchon, Korea, Republic of
๐ฐ๐ทYonsei University Severance Hospital, Seoul, Korea, Republic of
An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors
- Conditions
- First Posted Date
- 2008-04-14
- Last Posted Date
- 2008-04-18
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT00657176
- Locations
- ๐ฐ๐ท
Seoul National University Hospital, Seoul, Korea, Republic of
PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity
- Conditions
- Interventions
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2011-11-16
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 396
- Registration Number
- NCT00576706
Safety and Pharmacokinetics of Probucol and Cilostazol
- First Posted Date
- 2007-10-26
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT00549978
- Locations
- ๐ฐ๐ท
Clinical Trial Center, Seoul National University Hospital, Seoul, Korea, Republic of
Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
- Conditions
- First Posted Date
- 2007-10-26
- Last Posted Date
- 2007-10-26
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Registration Number
- NCT00549952
- Locations
- ๐ฐ๐ท
Seoul National University hospital, Seoul, Korea, Republic of
Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
- Conditions
- Interventions
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2010-08-12
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 146
- Registration Number
- NCT00545675
- Locations
- ๐ฐ๐ท
St. Mary's Hospital, Seoul, Korea, Republic of
Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
- Conditions
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2010-06-25
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 280
- Registration Number
- NCT00545142
- Locations
- ๐ฐ๐ท
St. Mary's hospital, Seoul, Korea, Republic of
Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)
- Conditions
- First Posted Date
- 2006-03-20
- Last Posted Date
- 2009-12-17
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT00304655
- Locations
- ๐ฐ๐ท
Seoul National University Hospital, Seoul, Korea, Republic of
SWitching to Abilify Trial (SWAT)
- Conditions
- First Posted Date
- 2006-03-20
- Last Posted Date
- 2009-12-17
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 500
- Registration Number
- NCT00304616
- Locations
- ๐ฐ๐ท
Asan Medical Center, Seoul, Korea, Republic of
Cilostazol in Acute Ischemic Stroke Treatment (CAIST)
- Conditions
- First Posted Date
- 2006-01-06
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 468
- Registration Number
- NCT00272454
- Locations
- ๐ฐ๐ท
Hallym University Sacred Heart Hospital, Ahnyang, Kyunggi Province, Korea, Republic of
๐ฐ๐ทInje University Ilsan Paik Hospital, Koyang, Kyunggi Province, Korea, Republic of
๐ฐ๐ทSeoul National University Bundang Hospital, Sungnam, Kyunggi Province, Korea, Republic of